¼¼°è ¼¼Æ÷ Áõ½Ä ½ÃÀå : Á¦Ç° À¯Çüº°, ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(-2029³â)
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
»óǰÄÚµå : 1453784
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 597 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,894,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,262,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,351,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,928,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼Æ÷ Áõ½Ä ½ÃÀå ±Ô¸ð´Â 2024³â 143¾ï ´Þ·¯¿¡¼­ 2029³â 267¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 13.3%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¾Ï µî ¸¸¼ºÁúȯ Áõ°¡À²Àº ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á, Á¶Á÷°øÇÐ, Àç»ýÀÇ·á µî ¼¼Æ÷ ±â¹Ý Ä¡·áÀÇ Çʿ伺À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ ¼¼Æ÷ ±â¹Ý Ä¡·á¹ý°ú ½Å±Ô Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ¼¼Æ÷ Áõ½ÄÀÇ Çʿ伺À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÇâÈÄ ¼ö³â°£ ¼¼Æ÷ Áõ½Ä ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³âµµ 2022³â-2029³â
±âÁسâ 2023³â
¿¹Ãø ±â°£ 2024³â-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(10¾ï ´Þ·¯)
ºÎ¹® Á¦Ç° À¯Çüº°, ¼¿ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

2023³â ¼¼°è ¼¼Æ÷ Áõ½Ä ½ÃÀå¿¡¼­ ¹ÙÀÌ¿À ÀǾàǰ »ý»ê ºÎ¹®Àº ¿ëµµº° ºÎ¹®¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰ »ý»ê¿¡´Â ´ÜŬ·ÐÇ×ü »ý»ê, ¹é½Å »ý»ê ¹× ±âŸ Ä¡·á¿ë ´Ü¹éÁú »ý»êÀÌ Æ÷ÇԵ˴ϴÙ. ½Å¾à °³¹ßÀ» À§ÇÑ ÅõÀÚ¿Í ÀÚ±Ý Á¶´Þ ½ÅÈï±¹ ½ÃÀå È®´ë, ´ÜŬ·ÐÇ×ü, ¹é½Å, Ä¡·á¿ë ´Ü¹éÁú µî »ý¹°ÇÐÀû ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ¼¼Æ÷ Áõ½Ä ½ÃÀå¿¡¼­ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

2023³â ºÏ¹ÌÀÇ ¼¼Æ÷ Áõ½Ä ½ÃÀåÀº ¹Ì±¹ÀÌ µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¼¼°è ÃÖ´ëÀÇ ¹ÙÀÌ¿À ÀǾàǰ ½ÃÀåÀÌ¸ç ¹ÙÀÌ¿À ÀǾàǰ ¿¬±¸/ÅõÀÚ ¸®´õÀÔ´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¿¡´Â ÇϹöµå ´ëÇÐ, ½ºÅÄÆ÷µå ´ëÇÐ, ¸Å»çÃß¼¼Ã÷ °ø°ú ´ëÇÐ(MIT) µî ¼¼°è ÃÖ°íÀÇ Çмú ¿¬±¸ ±â°üÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸±â°üÀº â¾à°ú »ý¸í°øÇÐÀ» Æ÷ÇÔÇÑ »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ ÃÖ÷´Ü ¿¬±¸¸¦ Çϰí ÀÖÀ¸¸ç, ¼¼Æ÷Áõ½Ä±â¼úÀÇ µµÀÔÀ» ¼ö¹ÝÇÏ¿© ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â °á°ú°¡ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Á¶Á÷°øÇÐ ¹× Àç»ýÀÇ·á ºÐ¾ß¿¡¼­ÀÇ ÀÚ±Ý Á¶´Þ Áõ°¡µµ ¼¼Æ÷ Áõ½Ä ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°è ¼¼Æ÷ Áõ½Ä ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Á¦Ç° À¯Çüº°, ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Áß¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ¼¼Æ÷ Áõ½Ä ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦7Àå ¼¼Æ÷ Áõ½Ä ½ÃÀå : ¼¼Æ÷ À¯Çüº°

Á¦8Àå ¼¼Æ÷ Áõ½Ä ½ÃÀå : ¿ëµµº°

Á¦9Àå ¼¼Æ÷ Áõ½Ä ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ¼¼Æ÷ Áõ½Ä ½ÃÀå : Áö¿ªº°

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦13Àå ºÎ·Ï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period of 2024 to 2029. The growth of this market can be attributed to increasing prevalence of chronic diseases. The rising rate of chronic diseases such as cancer is propelling the need of cell based therapies such as cell & gene therapy, tissue engineering, and regenerative medicine. The rising deamd for innovative cell based therapies and novel therapeutics is propelling the need of cell expansion. This trend is expected to drive the growth of the cell expansion market in the coming years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct, Cell Type, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The biopharmaceutical production segment accounted for the largest share of by application segment in 2023."

In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell expansion market. Biopharmaceutical production include monoclonal antibody production, vaccine production, and other therapeutic protein production. The growing investments and fundings for the development of novel drug products and rising demand for biological therapies such as monoclonal antibosies, vaccines, and therapeutic proteins are promoting the growth of biopharmaceutical production in cell expansion market.

"The US has continued to dominate the cell expansion market during the forecast period of 2024-2029."

The US dominated the cell expansion market in North America in 2023. The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world's leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery and biotechnology, which involve adoption of cell expansion techniques, resulting to propel the market growth. Additionally, increasing fundings in the field of tissue engineering and regenerative medicine are also driving the growth of cell expansion market.

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

This research report categorizes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, and other cell types), by application (biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell expansion market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. Also, it include new product launches, collaborations and acquisitions, and recent developments associated with the cell expansion market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell expansion market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 CELL EXPANSION MARKET, BY PRODUCT

7 CELL EXPANSION MARKET, BY CELL TYPE

8 CELL EXPANSION MARKET, BY APPLICATION

9 CELL EXPANSION MARKET, BY END USER

10 CELL EXPANSION MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â